Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03069729 · ClinicalTrials.gov registry record
Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)
A clinical trial of Diabetic Retinopathy and Diabetic Foot, sponsored by VisionQuest Biomedical.
- Completed
- Registry status
- 331
- Enrollment target
- 1
- Study location
NCT03069729 is a study of Diabetic Retinopathy and Diabetic Foot that has completed, run by VisionQuest Biomedical. The registered enrollment target is 331 participants, below the 1,671-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03069729, a study of Diabetic Retinopathy and Diabetic Foot, has completed, sponsored by VisionQuest Biomedical.
- COMPLETED
- Registry status
- 331 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research is to develop better tools for diagnosing illness of the feet and legs of people who have diabetes. Investigators will use thermal videos of the foot to aid in the refinement of a system designed to detect signs of diabetic peripheral neuropathy (DPN). The team of investigators will also look at diabetic eye disease and how it might relate to diabetic foot disease.
Conditions Studied
Interventions
- OTHER no intervention
Study Locations (1)
New Mexico
- VisionQuest Biomedical LLC - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 331 participants |
| Start Date | 2017-03-08 |
| Est. Completion | 2019-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03069729
The ClinicalTrials.gov registry entry for NCT03069729 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 331 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,671-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (80% lower). The listed sponsor is VisionQuest Biomedical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetic Retinopathy appearing as the primary indexed condition, and to 1 intervention - of which no intervention is the first listed.
NCT03069729 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.
Frequently Asked Questions
What is clinical trial NCT03069729 about?
NCT03069729 is a clinical study titled "Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)". The goal of this research is to develop better tools for diagnosing illness of the feet and legs of people who have diabetes. Investigators will use thermal videos of the foot to aid in the refinement of a system designed to detect signs of diabetic peripheral neuropathy (DPN). The team of investiga...
What is the current status of trial NCT03069729?
This trial is currently completed. The enrollment target is 331 participants. The study started on 2017-03-08. Estimated completion is 2019-09-01.
What conditions does trial NCT03069729 study?
This clinical trial studies the following conditions: Diabetic Retinopathy, Diabetic Foot, Diabetic Neuropathies.
What interventions are being tested in trial NCT03069729?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT03069729?
This trial is sponsored by VisionQuest Biomedical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03069729 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fenofibrate for Prevention of DR Worsening
RECRUITING · Phase 3
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
RECRUITING
-
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
RECRUITING · NA
-
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
RECRUITING · Phase 2
-
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.